Refine by
Cancer Disease Articles & Analysis
394 news found
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its new Tumor Organoid & CAF Co-culture services to provide researchers with a more physiologically relevant in vitro tumor model, enabling a deeper understanding of tumor-stromal interactions and the development of more effective cancer therapies. ...
Breast cancer remains one of the most challenging diseases to treat, especially for aggressive forms such as triple-negative breast cancer. ...
This limitation has made it difficult to fully grasp their contribution to health and disease. Recent scientific progress is now changing this picture. Researchers have developed innovative ways to study neutrophils by focusing on one of their most important components: lactoferrin. ...
Researchers have long recognized the importance of CCM in regulating cellular function and contributing to the understanding of various diseases, including cancer, diabetes, and neurodegenerative disorders. ...
These include E3 ligase ligands such as CRBN and VHL, and linkers which act as a mediator between target proteins and ligases to broaden the therapeutic options (especially in the treatment of cancer and neurodegenerative diseases). Nucleosides, the building blocks of nucleic acids, aren’t only simple building blocks for RNA and DNA. In medical ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, today announced the next step in the partnership between the Company and Genomenon, a leading genomic intelligence company, to support better, data-driven outcomes in the rare disease and oncology fields. The two companies have expanded the integration of Genomenon’s ...
During the event, the team demonstrated their pipeline from phage construction to screening and their masterpiece in discovering PTM specific antibodies, anti-idiotype antibodies, which gives researchers an edge when looking to discover novel targets in immunotherapy, cancer, and infectious diseases. Another hot topic during the festival was the growing interest ...
Historically, natural products have played a pivotal role in traditional healing systems, and modern science continues to exploit these compounds for their therapeutic potentials, particularly in combating cancerous and infectious diseases. Pharmaceutical chemicals, based on their source, are categorized as biobased, synthetic, or semi-synthetic. ...
Their versatility extends to applications in cancer treatment and wound healing, making them a significant focus of biotechnological research. Antibiotics, natural products predominantly produced by microorganisms, hold a crucial role in combating infectious diseases. Alfa Chemistry’s portfolio includes a diverse collection of antibiotics used in medical ...
This non-invasive testing allows for cancer genomic profiling and disease monitoring. It reveals critical insights in many cases where genomic testing of tumor tissue may not be feasible due to insufficient tissue material, low quality of the obtained tissue, or the invasiveness of the procedure. The ELBS primarily focuses on liquid biopsy testing for ...
This enhancement aims to offer more precise and comprehensive glycoprotein analysis, catering to the growing demands in the fields of biomedical research, disease biomarker discovery, and therapeutic development. Protein glycosylation, a major post-translational modification, significantly impacts protein folding, stability, and activity. Changes in glycoprotein abundance and ...
The portfolio features both a tumor-naïve assay and a tumor-informed assay that are designed to help detect residual disease or early cancer recurrence and monitor for immunotherapy treatment response, providing valuable insights to inform patient management strategies. ...
ByTempus
Dedicated to the research of new immunotherapeutic vaccines in oncology and prophylactic vaccines for contagious diseases, the aim of the joint Institut Pasteur – Oncovita laboratory is to design and develop vaccine candidates through to proof of concept in humans. ...
ByOncoVITA
Alfa Cytology, a premier contract research organization, recently launched its full-scale pancreatic cancer research services with robust platforms, powerful analytics, and cross-platform collaborations. Pancreatic cancer (PC) is a severe disease that is difficult to diagnose in the early stages due to its complex and hidden nature. ...
Small molecule drugs have a proven track record of success in treating a wide range of diseases, including cancer, cardiovascular disorders, and infectious diseases. By leveraging the potential of small molecules, our clients can benefit from: Targeted Therapies - Small molecules can be designed to selectively modulate specific biological ...
This comprehensive offering provides researchers with a powerful tool for studying various neurological disorders, including brain tumors, head and neck cancers, and neurodegenerative diseases. For example, Multiple Sites of Normal Brain Tissue Microarray, 80 Cases, 26 Cores (Catalog NO. ...
Their versatility has propelled their adoption in various research pursuits, including the exploration of cancer, inflammatory processes, and infectious diseases. Moreover, lectins have garnered attention in the commercial sphere, paving the way for the development of diagnostic tools, therapeutic agents, and food additives. ...
Inhibition of this enzyme can produce therapeutic effects in disease states like cancer, rheumatoid arthritis, and cardiovascular disease. ...
Stem cell therapy is a groundbreaking field in the pharmaceutical industry, offering powerful tools for treating severe diseases such as cancer. The genetic manipulations involved in this process, however, necessitate stringent regulations to ensure sterility and safety. ...
This critical information holds immense potential in unraveling immune responses, gaining insights into autoimmune diseases, advancing cancer immunotherapy, and propelling vaccine development. ...